Health Lean Analytics has secured more than €2.1m in funding, as the Barcelona-based company looks to expand its hospital data and AI platform.
The transaction combines private capital and public funding, with Novanta, a US-listed public company, acting as a technology and strategic partner.
HLA plans to use Novanta’s manufacturing and medical technology expertise, along with its access to the US market, to support this next phase of growth and validate its technology in a demanding environment. Novanta will be represented on HLA’s board of directors.
Mauro Batesteza, co-founder and co-chief executive of HLA, said: “The incorporation of Novanta as an advanced technology partner validates our technological and strategic strength and provides us with the resources and expertise needed to accelerate our R&D innovation.
“With this support, we will be able to initiate commercial deployment in the United States, a key market, and demonstrate how our technology transforms hospital management by increasing efficiency, safety and quality of patient care.
“This alliance undoubtedly marks the beginning of a new phase of international growth and the consolidation of our position as a benchmark in the sector.”
Founded in 2023, Health Lean Analytics is a hospital operations platform that uses data and artificial intelligence to turn real clinical and operational data into actionable insights, with the aim of improving how healthcare institutions are managed and perform.
The company develops tools based on data automation, the Internet of Things, advanced analytics and artificial intelligence, with a particular focus on the surgical suite, one of the most complex and critical environments within a hospital.
HLA says its technology passively captures clinical and operational data in real time without staff input.
It also integrates with existing hospital systems, bringing together data on patients, surgical materials, medication, operating room use and equipment management.
According to the company, it uses AI, large language models and operational agents to turn hospital data into real-time decisions that staff can act on.
Rather than simply displaying information, the platform interprets patterns, predicts deviations and recommends role-specific actions.
HLA says this cuts costs, improves use of surgical capacity, boosts safety and care quality, frees up clinical time and improves the experience of healthcare professionals.
John Lesica, co-chief operating officer of Novanta, said: “HLA has built a compelling AI and data analytics platform that transforms complex hospital operations into real-time, actionable intelligence.
“What excites us at Novanta is the convergence: our RFID and sensing technologies capture the data that powers HLA’s AI engine.
“Together, we’re closing the loop between physical hospital workflows and intelligent decision-making, a combination with the potential to fundamentally change how hospitals operate, starting with one of their most critical environments: the operating room.”
